Fentanyl, solution for injection, 0.05 mg/ml, 2 ml vials; Ketamine, solution for injection, 50 mg/ml, 2 ml vials; Morphine, solution for injection, 10 mg/ml, 1 ml vials; Diazepam, solution for injection, 5 mg/ml, 2 ml vials; Phenobarbital, tablets, 5 mg.

This tender concerns the procurement of essential anesthetic and sedative medications. The specified items include Fentanyl solution for injection (0.05 mg/ml, 2 ml vials), Ketamine solution for injection (50 mg/ml, 2 ml vials), Morphine solution for injection (10 mg/ml, 1 ml vials), Diazepam solution for injection (5 mg/ml, 2 ml vials), and Phenobarbital tablets (5 mg). These medications fall under CPV code 33660000-4, which covers medicinal preparations for the treatment of nervous system diseases and sensory organ diseases. The delivery timeframe is critical: within 3 working days of receiving an order from the Customer, during their working days (Monday-Friday). Delivery times may vary based on the facility's needs. This procurement is vital for medical facilities requiring these controlled substances for surgical procedures, pain management, and sedation. Bidders must comply with all regulations regarding the supply of pharmaceutical products, including proper storage, handling, and documentation.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals, Medical Equipment and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 183,300.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.